Newsroom

Proteona Selected Among Top 20 Startups for MedTech Innovator Asia Pacific Showcase

Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology

SINGAPORE, 18 September 2019 - Proteona Pte. Ltd. has been selected as one of the 20 best-in-class startups for the inaugural MedTech Innovator Asia Pacific Showcase, taking place in Singapore from 8th to 9th October. Proteona will present its ESCAPE™ single cell proteogenomic analysis technology, and how it can make a difference for advancing sophisticated cancer therapies such as cell therapy. Proteona will have the opportunity to present in front of key healthcare stakeholders and investors in the Asia Pacific region.

MedTech Innovator is the premier global nonprofit medtech competition and accelerator. The inaugural Asia Pacific Showcase is organized in partnership with the Asia Pacific Medical Technology Association. The showcase recognizes companies that fulfill a significant unmet healthcare need in the region. The showcase is part of the fifth Asia Pacific MedTech Forum.

Read the MedTech Innovator press release here.

Schedule a meeting


For media queries, please contact:

Dr Andreas Schmidt
Proteona
Email: info@proteona.com

About Proteona

Proteona Pte. Ltd. is a new biomedical company based in Singapore, Germany, and the US that is pioneering the use of DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research’s (A*STAR). The platform is a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.

www.proteona.com